Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact [email protected].
IRVINE, California-JenaValve Technology, Inc., developer and manufacturer of the JenaValve Pericardial Transcatheter Aortic Valve Replacement (TAVR) System for the treatment of aortic valve disease, announces that it has raised $50 million in an equity financing led by Bain Capital Life Sciences. Additional participants in the financing included existing investors Andera Partners, Gimv, Legend...
Emeryville, CA., August 12, 2019 – Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on commercializing novel vaccines, today announced Andrew A. F. Hack, M.D., Ph.D., a Managing Director at Bain Capital Life Sciences, has been appointed to Dynavax’s Board of Directors. The appointment follows an investment by Bain Capital Life Sciences in Dynavax’s...
SOUTH SAN FRANCISCO, CA, December 19, 2018 - Annexon Biosciences, a clinical stage biopharmaceutical company focused on the development of novel therapeutics through inhibition of the classical complement pathway, today announced that it has closed a $75 million Series C financing. The financing was led by new investor Bain Capital Life Sciences, with participation by Surveyor Capital (a Citadel...
SAN DIEGO, November 29, 2018 – ViaCyte, Inc., a privately-held clinical stage regenerative medicine company, today announced an $80 million Series D financing led by Bain Capital Life Sciences and joined by TPG and RA Capital Management, as well as existing investor, Sanderling Ventures, and several individual supporters of the Company. Proceeds from the financing will be used to further...
BOSTON and NEW YORK, October 23, 2018 – Bain Capital, LP and Pfizer Inc. (NYSE: PFE) today announced the creation of Cerevel Therapeutics, LLC (“Cerevel”), a new biopharmaceutical company focused on developing drug candidates to treat disorders of the central nervous system (CNS). Pfizer is contributing a portfolio of pre-commercial neuroscience assets to Cerevel, which include three...
LOWELL, MA, May 2, 2018 – Rapid Micro Biosystems, the leading provider of automated, growth-based, rapid microbial detection technology for the healthcare product manufacturing sector, announced that it has secured $60 million in equity financing led by new investors Bain Capital Life Sciences and Xeraya Capital. The new funding round also includes a commitment from another new investor, Asahi...
EVANSTON, ILLINOIS, December 18, 2017 – Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today is announcing the completion of a $70 million Series B financing to fund advancement of its expanding clinical-stage pipeline. The financing was led by Bain Capital Life Sciences. Additional new investors include Adage...
JENA, GERMANY, October 13, 2017 - InflaRx, the biopharmaceutical company developing new therapeutics in the terminal complement space, announced today a $ 55M Series D financing and investment round. The round was co-led by Bain Capital Life Sciences LP, Cormorant Asset Management LLC and RA Capital Management LLC and complemented by certain investment funds managed by a leading US investment...
NEW YORK, September 25, 2017 - SpringWorks Therapeutics, a mission-driven medicines company dedicated to developing innovative potential new treatments for underserved patient communities, announced its launch today with a completed $103 million Series A financing funded by Bain Capital Life Sciences, Bain Capital Double Impact, OrbiMed, Pfizer (NYSE:PFE) and LifeArc (formerly known as...
WOBURN, MA, September 8, 2017 – Replimune Group Inc., a biotechnology company focused on developing next generation oncolytic immunotherapies, announced today the completion of a $55 million Series B financing. The proceeds of the financing will primarily be used to generate human proof of concept data for its lead product, RP1, in multiple tumor types. The financing will also allow the Company...
For the ninth year, Cradles to Crayons will be fielding a team of runners in the Boston Marathon. Learn more about… https://t.co/I7O6qKsgJn
During the Million Match Challenge, donations to @Cycle4Survival can win matching dollars. Learn more. https://t.co/usR6qswzRK
The Safe and Sound Gala for @RosiesPlace will be Wednesday, May 6, 2020. Proceeds from the evening allow Rosie's Pl… https://t.co/kLOtquo2NK
Kanna Kunchala, senior vice president and chief of staff at @CityYear, reflects on 25 years of service. Read Kuncha… https://t.co/SkaXzxUcyZ
There are still routes available on Sunday, August 2 for #PMC2020. Register for the @PanMass Challenge now at https://t.co/AyHPztlHYI.
The 5th annual Taste the Cure to support @TheJimmyFund and @DanaFarber will be held on Friday, March 27, 2020. Lear… https://t.co/P3L8aLb75t
[email protected] events are held in 16 cities during January, February and March. Learn more about riding to raise… https://t.co/RBHP9qcf43
The 13th Annual @c2cboston Boston Bruins PJ Drive is underway with a goal of 13,000 pairs of pajamas for 13,000 chi… https://t.co/HlMIu0bY7r
[email protected] has received three fundraising bibs for the 2020 #BostonMarathon. Learn more about the runners or mak… https://t.co/g70Mrchvji
[email protected] has formal University Partnerships with 9 law schools for alumni who wish to enter the legal field. Lear… https://t.co/wSFBfAXop2